-The Hindu Business Line Mehsana (Gujarat): A monocropping culture, driven by healthy returns, threatens to hurt cotton farmers in Mehsana and other districts in the country's largest cotton-producing State, say agriculture experts working in the region. As the price of cotton slips due to excess supply and China scaling back on purchases, farmers in north Gujarat risk mounting their losses and the likelihood of reduced sowing in May. They had increased cotton...

-Vikalp Once again, India is under pressure from the US to revise its patent law. Anyone familiar with the activities of the United States Trade Representatives (USTR) would know that this is nothing new. It has been among the USTR's primary mandates to use trade restrictions in order to persuade (to put it mildly) countries to strengthen their IPR laws. There is, however, a qualitative difference between the actions it has...

-Deccan Chronicle THIRUVANANTHAPURAM: Don't worry if the fruits and vegetables you buy from the markets are contaminated with pesticides. Here is a solution Veggie Wash which will decontaminate them. The product developed by the pesticide residue lab of Kerala Agriculture University will hit the market this month. Around 10 companies have bought the formulation and another 10 are in the queue. Veggie Wash solution was standardised by M.Sc students...

-The Tribune BARC reports toxic metals in fertilisers as firms avoid costly decontamination process Bathinda (Punjab): The Bhabha Atomic Research Centre (BARC) has found high uranium content in diammonium phosphate and single superphosphate fertilisers that do not undergo the costlier decontamination process during production. The conclusion was reached after testing of soil and fertiliser samples. The Environmental Assessment Division of BARC sent a report on samples of DAP (diammonium phosphate) and single superphosphate...

-Business Standard Indian and other generic drug firms face prospect of US legislature debating compensation for undue price rises Indian generic drug makers might, if a proposed US law comes about, need to pay a rebate to the federal Medicaid programme there when prices of their medications outpace inflation. A Bill is to be introduced in the US Senate by a member, aimed to cushion the impact on taxpayers in this manner...